What is he best known for?
The fields of study he is best known for:
His primary areas of study are Pathology, Anaplastic astrocytoma, Mutation, Astrocytoma and Cancer research.
His Pathology research is multidisciplinary, incorporating elements of IDH1, Glioma, Internal medicine, Diffuse Astrocytoma and Oligodendroglioma.
His Anaplastic astrocytoma study combines topics in areas such as Phenotype, Biopsy, Angiocentric Glioma and Loss of heterozygosity.
His Mutation research is multidisciplinary, relying on both Tumor suppressor gene, Breast cancer and Exon.
His research investigates the connection between Astrocytoma and topics such as Grading that intersect with problems in Who classification, Large Cell Medulloblastoma, Rhabdoid Meningioma and Consensus conference.
Paul Kleihues has researched Cancer research in several fields, including Carcinogenesis, CDKN2A, Gene and Point mutation.
His most cited work include:
- The 2007 WHO Classification of Tumours of the Central Nervous System (10685 citations)
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
- World Cancer Report (2446 citations)
What are the main themes of his work throughout his whole career to date?
Paul Kleihues mostly deals with Pathology, Cancer research, Anaplastic astrocytoma, Molecular biology and Mutation.
He has included themes like Astrocytoma, Oligodendroglioma, Glioma and Neoplastic transformation in his Pathology study.
His Glioma research integrates issues from Necrosis, Fas receptor and Apoptosis.
His work deals with themes such as Tumor suppressor gene, Gene, Exon and Loss of heterozygosity, which intersect with Cancer research.
Paul Kleihues mostly deals with Diffuse Astrocytoma in his studies of Anaplastic astrocytoma.
The study incorporates disciplines such as Methylation, Biochemistry, Carcinogen, Locus and Alkyltransferase in addition to Molecular biology.
He most often published in these fields:
- Pathology (43.65%)
- Cancer research (34.92%)
- Anaplastic astrocytoma (19.84%)
What were the highlights of his more recent work (between 2003-2020)?
- Pathology (43.65%)
- Cancer research (34.92%)
- Anaplastic astrocytoma (19.84%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pathology, Cancer research, Anaplastic astrocytoma, Mutation and IDH1.
His Pathology research includes themes of Glioma, Internal medicine, Diffuse Astrocytoma, Loss of heterozygosity and Oligodendroglioma.
His Glioma research includes elements of Ependymoma and Meningioma.
His Cancer research study combines topics from a wide range of disciplines, such as Genetics, Receptor, Germline mutation, Germline and Fas receptor.
He interconnects Malignant transformation, Southern blot, Progressive multifocal leukoencephalopathy, Viral replication and Polymerase chain reaction in the investigation of issues within Anaplastic astrocytoma.
His research in Mutation intersects with topics in Molecular biology, Nitrosourea and Exon.
Between 2003 and 2020, his most popular works were:
- The 2007 WHO Classification of Tumours of the Central Nervous System (10685 citations)
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
- Genetic Pathways to Primary and Secondary Glioblastoma (1116 citations)
In his most recent research, the most cited papers focused on:
Pathology, Anaplastic astrocytoma, Diffuse Astrocytoma, Loss of heterozygosity and Glioma are his primary areas of study.
His work on Incidence as part of general Pathology study is frequently linked to PTEN, bridging the gap between disciplines.
His Anaplastic astrocytoma research incorporates elements of Mutation, IDH1, Angiocentric Glioma and Oligodendroglioma.
Paul Kleihues combines subjects such as Medulloblastoma, Ependymoma, Diffuse Glioma and Meningioma with his study of Diffuse Astrocytoma.
His Glioma research is multidisciplinary, incorporating perspectives in Methyltransferase, Primitive neuroectodermal tumor, Genetic predisposition and Etiology.
His studies in Cancer research integrate themes in fields like Disease and Anatomical pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
